Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.60+0.14 (+1.34%)
Close on Nov 17, 2026Market cap $891.37MP/E 13.8Yield –
Bioventus revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bioventus's revenue for the twelve months ending Jun 27, 2026 was $581.85M, up 3.1% year over year. For fiscal 2025 it was $568.09M, down 0.9% from the year before. The highest annual figure on record is $573.28M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $568.09M | -0.9% |
| FY2024 | Dec 31, 2024 | $573.28M | +11.9% |
| FY2023 | Dec 31, 2023 | $512.35M | +0.0% |
| FY2022 | Dec 31, 2022 | $512.12M | +18.8% |
| FY2021 | Dec 31, 2021 | $430.90M | +34.2% |
| FY2020 | Dec 31, 2020 | $321.16M | -5.6% |
| FY2019 | Dec 31, 2019 | $340.14M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | $153.21M | +3.8% |
| Q1 FY2026 | Mar 28, 2026 | $132.09M | +6.6% |
| Q4 FY2025 | Dec 31, 2025 | $157.90M | +2.8% |
| Q3 FY2025 | Sep 27, 2025 | $138.65M | -0.2% |
| Q2 FY2025 | Jun 28, 2025 | $147.66M | -2.4% |
| Q1 FY2025 | Mar 29, 2025 | $123.88M | -4.3% |
| Q4 FY2024 | Dec 31, 2024 | $153.64M | +13.5% |
| Q3 FY2024 | Sep 28, 2024 | $138.96M | +15.0% |
| Q2 FY2024 | Jun 29, 2024 | $151.22M | +10.3% |
| Q1 FY2024 | Mar 30, 2024 | $129.46M | +8.7% |
| Q4 FY2023 | Dec 31, 2023 | $135.42M | +7.6% |
| Q3 FY2023 | Sep 30, 2023 | $120.79M | -6.1% |
| Q2 FY2023 | Jul 1, 2023 | $137.07M | -2.3% |
| Q1 FY2023 | Apr 1, 2023 | $119.06M | +1.5% |
| Q4 FY2022 | Dec 31, 2022 | $125.83M | -3.5% |
| Q3 FY2022 | Oct 1, 2022 | $128.66M | +18.2% |
| Q2 FY2022 | Jul 2, 2022 | $140.33M | +27.8% |
| Q1 FY2022 | Apr 2, 2022 | $117.29M | +43.4% |
| Q4 FY2021 | Dec 31, 2021 | $130.41M | +32.3% |
| Q3 FY2021 | Oct 2, 2021 | $108.89M | +26.8% |
| Q2 FY2021 | Jul 3, 2021 | $109.82M | +89.3% |
| Q1 FY2021 | Apr 3, 2021 | $81.78M | +4.0% |
| Q4 FY2020 | Dec 31, 2020 | $98.59M | – |
| Q3 FY2020 | Sep 26, 2020 | $85.91M | – |
| Q2 FY2020 | Jun 27, 2020 | $58.02M | – |
| Q1 FY2020 | Mar 28, 2020 | $78.65M | – |
See a number that looks wrong?